Viatris price target lowered to $10 from $11 at BofA

BofA lowered the firm’s price target on Viatris (VTRS) to $10 from $11 and keeps an Underperform rating on the shares. The Q4 update was “highlighted by disappointing FY25 EBITDA guidance,” according to the analyst, who remains skeptical the company can execute on its pivot to a branded growth strategy.